Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nano-silver fluoride versus silver diamine fluoride for arrest of cavitated dental caries in preschool children
ACTRN12618001865202Phase 2Completed
- Sponsor
- Damascus University
- Start
- Nov 2018
- Modality
- Drug Delivery Systems, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of nanosilver fluoride, silver diamine fluoride and sterile water for injection in carious lesion (4 arms), sponsored by Damascus University. Primary endpoint: Caries arrest. Started Nov 2018; status: completed.
02
Drugs
nanosilver fluoridesilver diamine fluoridesterile water for injection
03
Conditions
carious lesion
Beyond the preview
Go deeper on ACTRN12618001865202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618001865202.